A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.
Clinical trial NCT01955564 · COMPLETED
Trial details
- NCT number
- NCT01955564
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.